Phreesia, Inc.
PHRHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframePhreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. At a $679.1M market cap, Phreesia, Inc. ranks as a small-cap company within healthcare. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions.
Market Cap
$679.1M
Beta
0.86
P/E (TTM)
60.78
P/E (Fwd)
6.81
EPS (TTM)
$0.18
EPS (Fwd)
$1.61
ROE
3.1%
ROA
2.6%
Cash
$72.9M
Total Debt
$67.9M
Free CF
$68.3M
52W Change
-59.2%
Annual Financials
Cash vs Debt
Where PHR stands vs its 150-day and 200-day moving averages
As of the August 21, 2026 close, PHR finished 10.19% above its 150-day moving average ($10.89) and 6.83% below its 200-day moving average ($12.88). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is PHR overbought or oversold?
At the August 21, 2026 close, PHR's RSI(14) was 64.9, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $72.9M in cash and $67.9M in debt, PHR maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $68.3M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 3.1%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.6% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $280.9M (2023) to $480.6M (2026), reflecting a 71% increase over the period.
The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Phreesia, Inc. and its sector.